Skip to content
Delayed ~15 min

ETON ETON PHARMACEUTCIALS INC

Health Care · Russell 2000

Next earnings: not announced yet

What 6 analyst firms say about ETON PHARMACEUTCIALS INC: their latest ratings, price targets and how far the stock is from them. How it works

56.46 USD+9.31 (+19.75%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+26.6%to the avg target 71.50 USD+15.04 USD
Buy 5 · Hold 0 · Sell 0

5 rated views · 6 analyst/firm records · 6 firms

Latest report15 Oct 2026avg report date 14 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8077
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8076

Recent analyst activity · last 90 days

Our tracked history has 8 reports on ETON from 6 analyst firms in the last 90 days (6 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target and 2 left it unchanged.

No firm's latest available rating differs from its previous one.

Latest observed target change: Craig Hallum raised its target from $35.00 (set 20 Mar 2026) to $78.00 on 15 Oct 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMadison El-SaadiBuy14 Aug 202670.00 USD
Canaccord GenuityGary NachmanBuy14 Aug 202668.00 USD
Craig-HallumChase KnickerbockerBuy15 Oct 202678.00 USD
H.C. WainwrightSwayampakula RamakanthBuy14 Oct 202670.00 USD
Weiss RatingsUnnamed analyst—22 Sep 2026—
Data feed RESEARCHResearch TeamBuy12 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 05:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.